Given Imaging (GIVN) Tops Q2 View
More News related to GIVN
- Oscar Gruss Upgrades Given Imaging Ltd. (GIVN) to Buy
- Given Imaging to Present at the Needham & Company Biotechnology and Medical Technology Conference
- New Clinical Study Shows Over Half of Eligible OGIB Patients May Benefit From Small Bowel Capsule Endoscopy as Recommended by GI Society Guidelines
- Study Concludes PillCam ESO(R) Correlates Well With EGD in Detecting and Grading Esophageal Varices -- A Potentially Lethal Complication of Advanced Liver Disease
- Study Confirms Given Imaging's Bravo(R) pH Monitoring System to Be a Very Effective Diagnostic Tool for Assessing GERD
Given Imaging Ltd. (Nasdaq: GIVN) reports Q2 EPS of $0.09, 7 cents better than the analyst estimate of $0.02. Revenues for the quarter were $33.1 million, versus the consensus of $32.07 million.
Related Categories
EarningsStocks Mentioned
-0.53Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
